The operators behind the rails.

Owns brand strategy, partnerships, new product, and the exit, and is the company’s public face across brand, media, and press alongside Adrian. Co-founded Thirstie, the “Shopify for alcohol,” which drew a strategic investment from RNDC and backing from an investor group that included former chief executives of Coach, Citibank, and Credit Suisse, before its acquisition by Cocktail Courier. An early investor in companies later acquired by Groupon and Hootsuite. Trained journalist; 25+ years across American Express, Deloitte, and Accenture.

“The brand is a story before it is a product. I make sure it is worth telling.”

Owns operations, growth, monetization, and retail, and leads legal. Co-founded ReserveBar in 2013, building the commercial platform behind the decade’s landmark celebrity spirits launches, including Aviation Gin, and the infrastructure powering brands later acquired by Diageo, Bacardi, and Proximo. The business was later backed by Silver Lake. Wharton MBA, Columbia JD.

“Most of it is unglamorous. That is the job.”

Owns brand, marketing, and creator programming. As Director of Branding at Aviation Gin, helped build an $8M regional label into its $610M Diageo acquisition, driving 300%+ volume growth. Later, at Ryan Reynolds’ Maximum Effort, launched Betty Buzz (Blake Lively) and Pantalones (Matthew McConaughey). Adweek Young Influential, 2020.

“The celebrity is the amplifier. The brand engine is the work.”

Holds the founders’ seat on the board. Decides where capital goes across the portfolio, which brands get more time and which get shut down, and the terms on which the company would sell.

Capital, corporate structure, and governance. Founder and CEO of Kiwi Ventures, an investor in 210-plus early-stage startups that connects with over 1,000 founders a month. Earlier co-founded Aptara, built to 5,000 employees and acquired for $144M. Three-time Inc. 500 honoree. Carnegie Mellon MBA.

“I have backed a lot of founders. The ones who worked out were rarely the ones who presented best.”

An investor and committed champion of the company, and a senior voice on partnerships, alliances, and international. An active NIH prime contractor with $80M-plus in federal relationships across HHS, NIH, and CMS, plus a senior researcher partnership at MIT that surfaces academic-spinout dealflow early.

“Conviction shows up in what you do when no one is asking.”